PRE 14A

PRE 14A Filing

Company: Eloxx Pharmaceuticals, Inc.
Filed: April 13, 2010
Period of Report: April 13, 2010
Accession Number: 0001144204-10-019767

View Document ↗ View on SEC.gov ↗